
Redhill Biopharma Ltd. stock delivered one of its most violent sessions recently. RDHL closed at 1.07, swinging between 1.01 and 1.60 on 947,205 shares. Buyers pushed sharply higher early, only for sellers to claw back most gains before the close — a classic exhaustion signal.
RDHL — daily chart with candlesticks, EMA20/EMA50 and volume.Key takeaways
- RDHL closed at 1.07 after an extreme intraday swing from 1.01 to 1.60 on heavy volume of 947,205 shares.
- Daily RSI14 reached 82.45, signaling deeply overbought conditions and elevated mean-reversion risk.
- Price closed well outside the daily Bollinger Bands, trading far above the upper band at 0.84.
- The close at 1.07 sat below the daily pivot of 1.23, despite a structurally bullish EMA alignment.
- Hourly RSI14 also registered overbought at 78.72, while the 15-minute MACD turned negative.
Redhill Biopharma Ltd. Stock Daily Chart: Structurally Bullish but Stretched
The daily chart paints a structurally bullish picture for Redhill Biopharma Ltd. stock — but one pushed to unsustainable extremes. Price closed well above all three key moving averages.
EMA Stack and Session Structure
On the daily timeframe, the EMA20 sits at 0.67, the EMA50 at 0.71, and the EMA200 at 0.97. This alignment — price above all three EMAs — is structurally bullish. It reflects just how far RDHL has travelled in a short period.
However, the close at 1.07 sits far below the session high of 1.60. That gap is a meaningful warning sign. A candle that opens near its low, spikes hard, and then gives back a large portion of the gain typically signals exhaustion rather than confirmation.
Momentum and Volatility Extremes
Notably, the daily RSI14 reads 82.45, deep into overbought territory. At this level, momentum has clearly outrun itself. Mean-reversion risk becomes elevated. The MACD line at 0.02 sits above its signal line at -0.02, with a histogram of 0.04. This is technically bullish, but modest compared to the scale of the price move.
Meanwhile, the Bollinger Bands tell an even more extreme story. The upper band is at 0.84 and the mid-band at 0.64. Wednesday’s close at 1.07 trades well outside the band structure entirely. That is a rare and aggressive extension. It usually does not persist without some form of pullback or consolidation.
Pivot and Regime Context
At the same time, the daily ATR14 stands at 0.10, confirming volatility has expanded sharply alongside the price move. Pivot levels add further nuance. The daily pivot point sits at 1.23, with resistance at 1.44 and support at 0.85. Notably, the close at 1.07 sits below the pivot. Despite the longer-term bullish EMA structure, the session closed on the weaker side of its own reference point.
The system’s daily regime reading, however, remains neutral. This reflects the internal conflict between an extended bullish structure and an inconclusive, volatile close.
Hourly Confirmation and RDHL Technical Analysis Signals
The hourly chart confirms a bullish trend for RDHL, but it shares the same overbought risk as the daily timeframe. On the 1-hour chart, price closed at 1.07, above the EMA20 at 0.80, the EMA50 at 0.70, and the EMA200 at 0.68. The regime here is explicitly tagged bullish, and the moving average stack supports that read.
In addition, the hourly MACD line at 0.11 sits above its signal at 0.06, with a histogram of 0.05. This reinforces near-term upward momentum.
Still, RSI14 on the hourly chart reads 78.72, which is also firmly overbought. The Bollinger upper band sits at 1.12, only slightly above the current close of 1.07. Price is pressing against the top of its own hourly volatility envelope. Therefore, the hourly picture confirms the daily bullish tilt in trend direction. But it does not offer fresh room to run without a pause.
The hourly pivot at 1.06, with resistance at 1.08 and support at 1.06, shows price is essentially glued to a tight decision zone right now.
15-Minute Execution Context
The 15-minute chart hints at cooling momentum, offering a more grounded short-term view than the hourly timeframe. Zooming into this lower timeframe, RSI14 sits at 61.26 — still constructive but notably cooler than the extreme readings on the higher timeframes.
More importantly, the MACD line at 0.08 has slipped just below its signal line at 0.10. This produces a negative histogram of -0.02. It is an early sign that short-term momentum is fading, even as the broader structure remains bullish.
The 15-minute EMA stack — 0.99, 0.85, and 0.70 for EMA20, EMA50, and EMA200 respectively — still favors buyers structurally. Bollinger Bands on this timeframe show price at 1.07, close to the mid-band of 1.03. Price sits well inside the band range between 0.70 and 1.36, unlike the extreme extension visible on the daily chart.
In other words, the shorter-term chart has room to consolidate without breaking the broader uptrend. This is a healthier setup than what the daily extension alone would suggest.
Bullish Scenario
For bulls to extend control, Redhill Biopharma Ltd. stock must hold key support and reclaim higher pivot levels. Specifically, RDHL would need to stay above the hourly pivot cluster near 1.06 and reclaim the daily pivot at 1.23. A push through the daily resistance at 1.44 would confirm that the rally has genuine follow-through rather than representing a one-day spike.
However, support from the EMA structure across all three timeframes would need to persist through any near-term cooling. The still-positive MACD histograms on the daily and hourly charts must also hold for buyers to regain full control.
Bearish Scenario
The bearish argument centers squarely on exhaustion — with overbought readings leaving almost no room for further upside without a correction first. An RSI of 82.45 on the daily chart and 78.72 on the hourly chart underscores how stretched the rally has become.
If price fails to hold the hourly support around 1.06 and slips back toward the daily support at 0.85, the bullish case would be invalidated. A daily close back below the EMA200 at 0.97 would be an even clearer signal. It would confirm that the recent spike was a volatility event rather than a genuine trend shift.
Closing Take
Overall, the setup in Redhill Biopharma Ltd. stock is a study in conflict between timeframes. The daily chart shows a stock that ripped higher on heavy volume but closed well off its highs. RSI and Bollinger readings remain at extreme, unsustainable levels.
Meanwhile, the hourly chart confirms the bullish trend structurally but shares the same overbought risk. The 15-minute chart hints at cooling short-term momentum. It offers a more grounded view of where price might consolidate next.
Given the elevated ATR readings across timeframes and the sharp intraday reversal already seen, volatility is likely to remain the dominant feature ahead. Positioning should account for the real possibility of sharp moves in either direction.
FAQ
What drove the extreme volatility in Redhill Biopharma Ltd. stock?
RDHL experienced an unusually wide intraday range, swinging from 1.01 to 1.60 on volume of 947,205 shares. Buyers drove the price sharply higher early in the session, but sellers erased most gains by the close at 1.07, leaving a textbook exhaustion candle.
Is Redhill Biopharma Ltd. stock overbought right now?
Yes, across multiple timeframes. The daily RSI14 reads 82.45 and the hourly RSI14 sits at 78.72, both firmly in overbought territory. Additionally, price closed well outside the daily Bollinger Bands — a rare extension that typically does not persist without a pullback or consolidation.
What are the key support levels to watch for RDHL?
The hourly pivot cluster near 1.06 serves as immediate support. Below that, the daily support at 0.85 becomes critical. A close below the EMA200 at 0.97 would invalidate the bullish structure and suggest the recent spike was a volatility event rather than a genuine trend shift.
Can the rally in Redhill Biopharma Ltd. stock continue?
It can, but only if RDHL holds above the hourly pivot near 1.06 and reclaims the daily pivot at 1.23. A push through 1.44 would confirm genuine follow-through. However, with RSI deeply overbought on both the daily and hourly charts, the path higher likely requires a consolidation phase first.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

2 hours ago
12









English (US) ·